- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01413282
Better Evaluation of Acute Chest Pain With Computed Tomography Angiography (BEACON)
Better Evaluation of Acute Chest Pain With Computed Tomography Angiography - A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Myocardial infarction remains one of the most important causes of death and disability. Therefore it is important that individuals with acute chest pain are accurately assessed without delaying appropriate treatment. Acute coronary syndrome is only one cause for sudden chest pain, which is a very common complaint in the ER. Other life threatening causes such as pulmonary embolism and aortic dissection may also be the cause, although most chest discomfort has a benign reason (musculoskeletal, hyperventilation, oesophageal reflux, etc).
The current work-up of suspected acute coronary syndrome, based on presentation, symptoms, ECG and biomarkers, is not efficient and results in unnecessary diagnostics and hospital admissions, as well as errors or delayed diagnoses, in a substantial number of patients. Computed tomography angiography (CTA) images atherosclerosis, coronary obstruction as well as myocardial hypoperfusion. We hypothesize that early use of CTA is of incremental value and allows for accurate and immediate triage of patients with acute chest pain.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rotterdam, Netherlands
- Erasmus MC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Acute chest pain or equivalent
- Patients older than 30 years
- Males < 75 years and Females < 80 years
Exclusion Criteria:
- STEMI
- Troponin > 0.1
- History of known myocardial infarction, PCI or CABG
- Pregnancy
- Contrast allergy
- Renal disfunction
- No informed consent possible
- No follow-up possible
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Cardiac CT
Triage based on cardiac CT results.
|
Calcium scan and CT coronary angiography
|
|
No Intervention: Standard Care
Standard diagnostic management according to the European guidelines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Successful discharge rate
Time Frame: 30 days
|
The proportion of patients discharged home without major adverse events during the following 30 days.
Major adverse events are cardiovascular death or non-fatal myocardial infarction.
|
30 days
|
|
Diagnostic yield of invasive angiography
Time Frame: 30 days
|
Number of patients identified with severe coronary artery disease identified by invasive angiography requiring revascularisation according to the international guidelines.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Successful discharge rate for all adverse events
Time Frame: 30 days
|
The proportion of patients discharged home without any adverse events during the following 30 days.
Adverse events are cardiovascular death, non-fatal myocardial infarction, unstable angina, coronary revascularization, repeat hospital visits for chest pain.
|
30 days
|
|
Major adverse events
Time Frame: 6 months
|
Composite endpoint of major adverse cardiac events at 6 months: cardiovascular death, non-fatal myocardial infarction, unstable angina, coronary revascularisation and repeat hospital visits for chest pain.
|
6 months
|
|
Acute coronary syndrome
Time Frame: Index hospital visit
|
Diagnosis of acute coronary syndrome, according to international guidelines, at time of discharge.
|
Index hospital visit
|
|
Missed myocardial infarctions
Time Frame: 2 days
|
Missed myocardial infarctions, at 2-day follow-up, in patients discharged from the emergency department.
|
2 days
|
|
Duration of hospital stay
Time Frame: Index hospital visit
|
Duration of hospital stay
|
Index hospital visit
|
|
Direct medical cost
Time Frame: 30 days
|
Direct medical costs until 30th day after ED visit.
|
30 days
|
|
Radiation exposure
Time Frame: 6 months
|
Cumulative medical radiation exposure at 6 months.
|
6 months
|
|
Renal function
Time Frame: 2 days
|
Change in renal function after 2 days.
|
2 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Koen Nieman, MD, PhD, Erasmus MC
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BEACON-11
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Chulalongkorn UniversityCompletedCKD | Coronary Angiography (CAG) | ACS (Acute Coronary Syndrome)
-
Mahidol UniversityNot yet recruitingCoronary Artery Disease | Acute Coronary Syndrome/ Myocardial InfarctionThailand
-
Aarhus University Hospital SkejbyAbbottEnrolling by invitationIschemic Heart Disease | Ischemic Coronary Artery Disease | ACS (Acute Coronary Syndrome)Denmark, Belgium, Finland, Sweden, Switzerland, Germany, Latvia, Norway, United Kingdom, Estonia, Netherlands, Italy
-
Shenyang Northern HospitalNot yet recruitingSGLT2 Inhibitors | ACS (Acute Coronary Syndrome)China
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
Heart Care FoundationNovartis Farma S.p.A.Not yet recruitingAcute Coronary Syndromes | Chronic Coronary SyndromesItaly
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Xiling QiRecruitingHF - Heart Failure | ACS (Acute Coronary Syndrome)China
-
Shenyang Northern HospitalChinese Academy of Medical Sciences, Fuwai HospitalNot yet recruitingCoronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS) | High Bleeding Risk(HBR)China
-
Tongji HospitalRecruiting
Clinical Trials on Cardiac CT
-
Assiut UniversityNot yet recruitingCardiac Congenital Defects
-
Das Radiologische ZentrumHeidelberg UniversityRecruiting
-
Piedmont HealthcareCompletedCoronary Artery DiseaseUnited States
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioRecruitingHigh-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction (FAMILY)Coronary Artery DieaseItaly
-
Hospital of South West JutlandUniversity of Southern Denmark; The Danish Diabetes Academy supported by the... and other collaboratorsUnknownDiabetes | Atherosclerosis | PlaqueDenmark
-
Odense University HospitalUnknownCoronary ArteriosclerosisDenmark
-
Guy's and St Thomas' NHS Foundation TrustUnknownCoronary Artery Disease | Chest Pain | Acute Coronary Syndrome | Ischemic Heart DiseaseUnited Kingdom
-
Medical University of ViennaUniversity College, LondonUnknown
-
NHS Greater Glasgow and ClydeTerminatedCardiovascular Diseases | Chronic Kidney Diseases | Cardiomyopathies | Cardiac DiseaseUnited Kingdom